CL
REGN icon

Choreo LLC’s Regeneron Pharmaceuticals REGN Stock Holding History

Choreo LLC’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.44M Sell
5,514
-661
-11% -$450K 0.04% 299
2026
Q1 		$4.77M Buy
6,175
+743
+14% +$569K 0.06% 224
2025
Q4 		$4.2M Sell
5,432
-71
-1% -$48.2K 0.05% 224
2025
Q3 		$3.09M Buy
5,503
+533
+11% +$301K 0.04% 280
2025
Q2 		$2.61M Buy
4,970
+1,224
+33% +$683K 0.04% 305
2025
Q1 		$2.38M Buy
3,746
+32
+0.9% +$22K 0.04% 300
2024
Q4 		$2.62M Sell
3,714
-321
-8% -$269K 0.04% 289
2024
Q3 		$4.22M Buy
4,035
+250
+7% +$278K 0.06% 214
2024
Q2 		$4M Buy
3,785
+2,702
+249% +$2.62M 0.07% 191
2024
Q1 		$1.04M Buy
1,083
+36
+3% +$34.2K 0.03% 267
2023
Q4 		$920K Buy
+1,047
New +$862K 0.02% 278

Other funds holding REGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Choreo LLC's REGN Position: Q2 2026 in Review

Choreo LLC reduced its Regeneron Pharmaceuticals (REGN) stake by 11% in Q2 2026, selling an estimated $450K and leaving 5,514 shares worth $3.44M. The position accounts for 0.04% of the portfolio, ranked #299.

Choreo LLC first reported a position in REGN in Q4 2023 and has held it in 11 quarters since. The position peaked at $4.77M in Q1 2026. 1,335 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • Choreo LLC held 5,514 shares of Regeneron Pharmaceuticals worth $3.44M as of Q2 2026.
  • Choreo LLC sold 661 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $450K.
  • Regeneron Pharmaceuticals made up 0.04% of Choreo LLC's portfolio in Q2 2026, its #299 holding.
  • Choreo LLC first reported a position in Regeneron Pharmaceuticals in Q4 2023 and has held it in 11 quarters since.
  • Choreo LLC's Regeneron Pharmaceuticals position peaked at $4.77M in Q1 2026.
  • 1,335 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Choreo LLC's 13F filing for Q2 2026, filed 4 Aug 2026.